Skip to main content

Alzheimer’s

Disease

What is Alzheimer’s Disease?

Alzheimer’s is a devastating, progressive disease that destroys memory and other important mental functions, mainly in the older (65+) population. Brain cell connections and the cells themselves degenerate and die, eventually destroying memory and other important mental functions. Memory loss and confusion are the main symptoms. Unfortunately, no cure exists, but medications and management strategies may temporarily improve symptoms.

Approximately 6.7 million Americans aged 65 and older are living with Alzheimer’s Disease. This number is expected to nearly double by 2060, highlighting the growing need for research and effective treatments.

High performing Summit sites are actively participating in Alzheimer’s Disease studies

Similar study issues as MASH clinical trials
  • Complex imaging requirements
  • High screen failure
Leveraging Summit’s SME/KOL Experience
  • Trial design
  • Scientific support
  • Recruitment support for sites

Based upon our Alzheimer’s experience, Summit provides:

  • Rapid site start-up
  • Flexible strategies for patient and caregiver engagement
  • Patient recruitment and retention strategies
  • Sites with strong Alzheimer’s track record
  • Certified raters at sites
  • Strategies for rater training and qualification

Interested in learning more about

our Alzheimers studies?

Contact Us